Oxidation of apolipoprotein A-I by myeloperoxidase impairs the initial interactions with ABCA1 required for signaling and cholesterol export1

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Lipid Research

• Publication date

  2010-07-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1194/jlr.M004085PMID 20064972PMCID PMC2882738
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Correction for Genetic inactivation of AKT1, AKT2, and PDPK1 in human colorectal cancer cells clarifies their roles in tumor growth regulation

  2010cited by this paper
• ABCA1 mutants reveal an interdependency between lipid export function, apoA-I binding activity, and Janus kinase 2 activation ** This work was supported by National Institutes of Health Grant RO1HL-55362. Published, JLR Papers in Press, September 5, 2008.

  2009cited by this paper
• Using tandem mass spectrometry to quantify site-specific chlorination and nitration of proteins: model system studies with high-density lipoprotein oxidized by myeloperoxidase.

  2008cited by this paper
• Apolipoprotein A-I Tryptophan Substitution Leads to Resistance to Myeloperoxidase-Mediated Loss of Function

  2008cited by this paper
• The Structure of Apolipoprotein A-I in High Density Lipoproteins*

  2007cited by this paper
• ABCA1-Induced Cell Surface Binding Sites for ApoA-I

  2007cited by this paper
• Myeloperoxidase and inflammatory proteins: Pathways for generating dysfunctional high-density lipoprotein in humans

  2007cited by this paper
• Electron Paramagnetic Resonance Spectroscopy of Site-directed Spin Labels Reveals the Structural Heterogeneity in the N-terminal Domain of ApoA-I in Solution*

  2007cited by this paper
• Identification of an ABCA1-dependent phospholipid-rich plasma membrane apolipoprotein A-I binding site for nascent HDL formation: implications for current models of HDL biogenesis Published, JLR Papers in Press, July 26, 2007.

  2007cited by this paper
• Mechanism of ATP-binding Cassette Transporter A1-mediated Cellular Lipid Efflux to Apolipoprotein A-I and Formation of High Density Lipoprotein Particles*

  2007cited by this paper
• Apolipoprotein A-I activates Cdc42 signaling through the ABCA1 transporter Published, JLR Papers in Press, January 28, 2006.

  2006cited by this paper
• Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis

  2006cited by this paper
• Myeloperoxidase Impairs ABCA1-dependent Cholesterol Efflux through Methionine Oxidation and Site-specific Tyrosine Chlorination of Apolipoprotein A-I*

  2006cited by this paper
• Janus kinase 2 modulates the lipid-removing but not protein-stabilizing interactions of amphipathic helices with ABCA1 Published, JLR Papers in Press, October 6, 2005.

  2006cited by this paper
• ABCA1 and ABCG1 or ABCG4 act sequentially to remove cellular cholesterol and generate cholesterol-rich HDL Published, JLR Papers in Press, August 10, 2006.

  2006cited by this paper
• ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease.

  2005cited by this paper
• Tyrosine 192 in Apolipoprotein A-I Is the Major Site of Nitration and Chlorination by Myeloperoxidase, but Only Chlorination Markedly Impairs ABCA1-dependent Cholesterol Transport*

  2005cited by this paper
• Localization of Nitration and Chlorination Sites on Apolipoprotein A-I Catalyzed by Myeloperoxidase in Human Atheroma and Associated Oxidative Impairment in ABCA1-dependent Cholesterol Efflux from Macrophages*

  2005cited by this paper
• Advanced glycation end product precursors impair ABCA1-dependent cholesterol removal from cells.

  2005cited by this paper
• Apolipoprotein A-I Activates Cellular cAMP Signaling through the ABCA1 Transporter*

  2004cited by this paper
• Janus Kinase 2 Modulates the Apolipoprotein Interactions with ABCA1 Required for Removing Cellular Cholesterol*

  2004cited by this paper
• ABCA1 and amphipathic apolipoproteins form high-affinity molecular complexes required for cholesterol efflux Published, JLR Papers in Press, November 16, 2003. DOI 10.1194/jlr.M300355-JLR200

  2004cited by this paper
• Cross-linking and lipid efflux properties of apoA-I mutants suggest direct association between apoA-I helices and ABCA1.

  2004cited by this paper
• Human Atherosclerotic Intima and Blood of Patients with Established Coronary Artery Disease Contain High Density Lipoprotein Damaged by Reactive Nitrogen Species*

  2004cited by this paper
• Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease.

  2004cited by this paper
• α-Helix Formation Is Required for High Affinity Binding of Human Apolipoprotein A-I to Lipids*

  2004cited by this paper
• The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport.

  2004cited by this paper
• ABCA1 redistributes membrane cholesterol independent of apolipoprotein interactions Published, JLR Papers in Press, April 16, 2003. DOI 10.1194/jlr.M300078-JLR200

  2003cited by this paper
• Efflux and Atherosclerosis The Clinical and Biochemical Impact of Variations in the ABCA1 Gene

  2003cited by this paper
• A PEST sequence in ABCA1 regulates degradation by calpain protease and stabilization of ABCA1 by apoA-I.

  2003cited by this paper
• Apolipoprotein A-I Activates Protein Kinase Cα Signaling to Phosphorylate and Stabilize ATP Binding Cassette Transporter A1 for the High Density Lipoprotein Assembly*

  2003cited by this paper
• Unsaturated Fatty Acids Inhibit Cholesterol Efflux from Macrophages by Increasing Degradation of ATP-binding Cassette Transporter A1*

  2002cited by this paper
• Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues

  2002cited by this paper
• Naturally Occurring Mutations in the Largest Extracellular Loops of ABCA1 Can Disrupt Its Direct Interaction with Apolipoprotein A-I*

  2002cited by this paper
• Helical Apolipoproteins Stabilize ATP-binding Cassette Transporter A1 by Protecting It from Thiol Protease-mediated Degradation*

  2002cited by this paper
• Myeloperoxidase produces nitrating oxidants in vivo.

  2002cited by this paper
• Neutrophils employ the myeloperoxidase system to generate antimicrobial brominating and chlorinating oxidants during sepsis

  2001cited by this paper
• Specific Binding of ApoA-I, Enhanced Cholesterol Efflux, and Altered Plasma Membrane Morphology in Cells Expressing ABC1*

  2000cited by this paper
• ABCA1 Is the cAMP-inducible Apolipoprotein Receptor That Mediates Cholesterol Secretion from Macrophages*

  2000cited by this paper
• Oxidation of Methionine Residues to Methionine Sulfoxides Does Not Decrease Potential Antiatherogenic Properties of Apolipoprotein A-I*

  2000cited by this paper
• Apolipoprotein binding to protruding membrane domains during removal of excess cellular cholesterol.

  2000cited by this paper
• Atherosclerotic Plaques : Colocalization of Biglycan With Apolipoproteins Comparison of Apolipoprotein and Proteoglycan Deposits in Human Coronary

  1998cited by this paper
• Mass Spectrometric Quantification of Markers for Protein Oxidation by Tyrosyl Radical, Copper, and Hydroxyl Radical in Low Density Lipoprotein Isolated from Human Atherosclerotic Plaques*

  1997cited by this paper
• Formation of Nitrating and Chlorinating Species by Reaction of Nitrite with Hypochlorous Acid

  1996cited by this paper
• Oxidative chemistry of peroxynitrite.

  1994cited by this paper
• Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions.

  1994cited by this paper
• Dityrosine, a specific marker of oxidation, is synthesized by the myeloperoxidase-hydrogen peroxide system of human neutrophils and macrophages.

  1993cited by this paper
• Protein kinase C as a mediator of high density lipoprotein receptor-dependent efflux of intracellular cholesterol.

  1991cited by this paper
• Leukocytic oxygen activation and microbicidal oxidative toxins.

  1989cited by this paper
• Protein labeling by reductive alkylation.

  1983cited by this paper
• [50] Protein labeling by reductive alkylation

  1983cited by this paper
• Kinetics and mechanism of association of human plasma apolipoproteins with dimyristoylphosphatidylcholine: effect of protein structure and lipid clusters on reaction rates.

  1981cited by this paper
• Kinetics of lipid--protein interactions: interaction of apolipoprotein A-I from human plasma high density lipoproteins with phosphatidylcholines.

  1978cited by this paper
• Enthalpy of decomposition of hydrogen peroxide by catalase at 25 degrees C (with molar extinction coefficients of H 2 O 2 solutions in the UV).

  1972cited by this paper
• Enthalpy of Decomposition of Hydrogen Peroxide by Catalase at 25C (with Molar Extinction Coefficients of H2O2 Solutions in the UV)

  1972cited by this paper

• Different Mechanisms in Doxorubicin-Induced Neurotoxicity: Impact of BRCA Mutations

  2025cites this paper
• Associations between lipid parameters and depression with the moderating role of inflammation: Network analyses of 87,636 UK Biobank participants.

  2025cites this paper
• Association of High-Density Lipoprotein Cholesterol with the Top 10 Causes of Death.

  2025cites this paper
• High-density lipoproteins, Part 1. Epidemiology, antiatherogenic effects, and therapies designed to increase their serum levels

  2025cites this paper
• High-density lipoproteins. Part 2. Impact of disease states on functionality

  2025cites this paper
• Enhancing Wound Healing and Anti-Inflammatory Effects by Combination of CIGB-258 and Apolipoprotein A-I against Carboxymethyllysine Toxicity in Zebrafish: Insights into Structural Stabilization and Antioxidant Properties

  2024cites this paper
• Cholesterol Efflux Capacity and Its Association with Oxidative Stress in Myocardial Infarction

  2024cites this paper
• Dysfunctional HDL Diagnostic Metrics for Cardiovascular Disease Risk Stratification: Are we Ready to Implement in Clinics?

  2024cites this paper
• Hypochlorous acid induces a redox-dependent growth of C2C12 myoblasts.

  2024cites this paper
• High-Density Lipoprotein Modifications: Causes and Functional Consequences in Type 2 Diabetes Mellitus

  2024cites this paper
• Changes in high-density lipoprotein cholesterol with risk of Cardiovascular Disease among initially high-density lipoprotein-high participants

  2023cites this paper
• Anthracycline-induced cardiotoxicity: targeting high-density lipoproteins to limit the damage?

  2022cites this paper
• Understanding Myeloperoxidase-Induced Damage to HDL Structure and Function in the Vessel Wall: Implications for HDL-Based Therapies

  2022influential citation
• The OSE complotype and its clinical potential

  2022cites this paper
• Scavenging dicarbonyls with 5′-O-pentyl-pyridoxamine increases HDL net cholesterol efflux capacity and attenuates atherosclerosis and insulin resistance

  2022cites this paper
• Using adenovirus-mediated gene transfer to study the effect of myeloperoxidase on plasma lipid levels, HDL structure and functionality in mice expressing human apoA-I forms.

  2022cites this paper
• Subpopulations of High-Density Lipoprotein: Friends or Foes in Cardiovascular Disease Risk in Chronic Kidney Disease?

  2021cites this paper
• Effect of myeloperoxidase oxidation and N-homocysteinylation of high-density lipoprotein on endothelial repair function

  2021cites this paper
• High Density Lipoprotein Cholesterol Efflux Capacity and Atherosclerosis in Cardiovascular Disease: Pathophysiological Aspects and Pharmacological Perspectives

  2021cites this paper
• Study of Lipid Profile in Chronic Kidney Disease Patients

  2021cites this paper
• HDL and type 2 diabetes: the chicken or the egg?

  2021cites this paper
• Connecting Cholesterol Efflux Factors to Lung Cancer Biology and Therapeutics

  2021cites this paper
• Dysfunctional High-Density Lipoproteins in Type 2 Diabetes Mellitus: Molecular Mechanisms and Therapeutic Implications

  2021cites this paper
• Interaction between high-density lipoproteins and inflammation: Function matters more than concentration!

  2020cites this paper
• Site-specific 5-hydroxytryptophan incorporation into apolipoprotein A-I impairs cholesterol efflux activity and high-density lipoprotein biogenesis

  2020cites this paper
• The Role and Function of HDL in Patients with Chronic Kidney Disease and the Risk of Cardiovascular Disease

  2020cites this paper
• Natural products: The role and mechanism in low‐density lipoprotein oxidation and atherosclerosis

  2020cites this paper
• LDL and HDL Oxidative Modification and Atherosclerosis.

  2020cites this paper
• Reactive Dicarbonyl Scavenging Effectively Reduces MPO-Mediated Oxidation of HDL and Restores PON1 Activity

  2020cites this paper
• Lipid Transfer in Lipoprotein Metabolism and Cardiovascular Disease

  2020cites this paper
• Dysfunctional high-density lipoprotein: the role of myeloperoxidase and paraoxonase-1.

  2020cites this paper
• Lipid Peroxidation in Atherosclerotic Cardiovascular Diseases

  2020cites this paper
• Associations of low HDL cholesterol level and premature coronary heart disease with functionality and phospholipid composition of HDL and with plasma oxLDL antibody levels

  2019cites this paper
• Dysfunctional HDL as a Therapeutic Target for Atherosclerosis Prevention.

  2019cites this paper
• Reactive Dicarbonyl Scavenging Effectively Reduces MPO-Mediated Oxidation of HDL and Preserves HDL Atheroprotective Functions

  2019cites this paper
• Kidney as modulator and target of “good/bad” HDL

  2018cites this paper
• Novel Mechanism of Regulation of the 5-lipoxygenase/leukotriene B4 Pathway by High-Density Lipoprotein in Macrophages

  2018cites this paper
• Myeloperoxidase modification of high-density lipoprotein suppresses human endothelial cell proliferation and migration via inhibition of ERK1/2 and Akt activation.

  2018cites this paper
• Dysfunctional HDL in diabetes mellitus and its role in the pathogenesis of cardiovascular disease

  2018cites this paper
• Apolipoprotein A-I exchange is impaired in metabolic syndrome patients asymptomatic for diabetes and cardiovascular disease

  2017cites this paper
• Tyrosine-Nitrated Proteins: Proteomic and Bioanalytical Aspects

  2017cites this paper
• Chapter 3 – Degenerated HDL and Its Clinical Implications

  2017cites this paper
• Cholesterol Uptake Capacity: A New Measure of HDL Functionality for Coronary Risk Assessment.

  2017influential citation
• Role of Hypohalous Acids in Basement Membrane Homeostasis

  2017cites this paper
• Lipid-free apoA-I structure - Origins of model diversity.

  2017cites this paper
• Novel mechanism of regulation of the 5-lipoxygenase/leukotriene B4 pathway by high-density lipoprotein in macrophages

  2017cites this paper
• Deposition Patterns and Localization of Apolipoprotein A 1 and Their Relation to Plaque Morphology in Human Coronary Artery

  2017cites this paper
• Oxidative Stress in Human Atherothrombosis: Sources, Markers and Therapeutic Targets

  2017cites this paper
• High-density lipoprotein, mitochondrial dysfunction and cell survival mechanisms.

  2016cites this paper
• Dysfunctional high-density lipoproteins in coronary heart disease: implications for diagnostics and therapy.

  2016cites this paper
• Malondialdehyde Epitopes as Targets of Immunity and the Implications for Atherosclerosis.

  2016influential citation
• Serum amyloid A impairs the antiinflammatory properties of HDL.

  2016cites this paper
• Cholesterol Efflux Capacity of Apolipoprotein A-I Varies with the Extent of Differentiation and Foam Cell Formation of THP-1 Cells

  2016cites this paper
• Reactive Oxygen Species and Neutrophil Function.

  2016cites this paper
• Relationship between selected oxidative stress markers and lipid risk factors for cardiovascular disease in middle-aged adults and its possible clinical relevance.

  2016cites this paper
• Dysfunctional HDL and atherosclerotic cardiovascular disease

  2016cites this paper
• Serum amyloid A impairs the antiinflammatory properties of HDL.

  2016cites this paper
• Effect of inflammation on HDL structure and function

  2016cites this paper
• Myeloperoxidase-mediated Methionine Oxidation Promotes an Amyloidogenic Outcome for Apolipoprotein A-I*

  2015cites this paper
• Dysfunctional High-Density Lipoprotein: An Innovative Target for Proteomics and Lipidomics

  2015cites this paper
• HDL from apoA1 transgenic mice expressing the 4WF isoform is resistant to oxidative loss of function[S]

  2015cites this paper
• Effects of Myeloperoxidase-Induced Oxidation on Antiatherogenic Functions of High-Density Lipoprotein

  2015cites this paper
• Residual Cardiovascular Risk in Chronic Kidney Disease: Role of High-density Lipoprotein.

  2015cites this paper
• High-density lipoproteins at the interface between central nervous system and plasma lipoprotein metabolism

  2015cites this paper
• Dysfunctional HDL: from structure-function-relationships to biomarkers.

  2015cites this paper
• A Cluster of Proteins Implicated in Kidney Disease Is Increased in High-Density Lipoprotein Isolated from Hemodialysis Subjects.

  2015cites this paper
• HDL-apolipoprotein A-I exchange is independently associated with cholesterol efflux capacity

  2015cites this paper
• Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity[S]

  2015cites this paper
• Effects of heavy alcohol intake on lipoproteins, adiponectin and cardiovascular risk

  2014cites this paper
• Reverse Cholesterol Transport in HDL Metabolism: Modulation of Structural and Functional Features of HDL Particles

  2014cites this paper
• Multimarker Screening of Oxidative Stress in Aging

  2014cites this paper
• Humans With Atherosclerosis Have Impaired ABCA1 Cholesterol Efflux and Enhanced High-Density Lipoprotein Oxidation by Myeloperoxidase

  2014cites this paper
• Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex.

  2013cites this paper
• HDL-apoA-I Exchange: Rapid Detection and Association with Atherosclerosis

  2013cites this paper
• High Density Lipoprotein: Assembly, Structure, Cargo, and Functions

  2013cites this paper
• Site-specific oxidation of apolipoprotein A-I impairs cholesterol export by ABCA1, a key cardioprotective function of HDL.

  2012cites this paper
• HDL dysfunction in diabetes: causes and possible treatments

  2012cites this paper
• Influence of C-terminal α-helix hydrophobicity and aromatic amino acid content on apolipoprotein A-I functionality.

  2012cites this paper
• Genetics of Cholesterol Efflux

  2012cites this paper
• Preservation of biological function despite oxidative modification of the apolipoprotein A-I mimetic peptide 4F

  2012cites this paper
• Dysfunctional high-density lipoprotein in patients on chronic hemodialysis.

  2012cites this paper
• The positional specificity of EXXK motifs within an amphipathic α-helix dictates preferential lysine modification by acrolein: implications for the design of high-density lipoprotein mimetic peptides.

  2012cites this paper
• Tyrosine Modifications in Aging

  2012cites this paper
• Extra-virgin olive oil consumption improves the capacity of HDL to mediate cholesterol efflux and increases ABCA1 and ABCG1 expression in human macrophages

  2012cites this paper
• High-density lipoprotein cholesterol efflux, nitration of apolipoprotein A-I, and endothelial function in obese women.

  2012cites this paper
• Erythrocytes, leukocytes and platelets as a source of oxidative stress in chronic vascular diseases: Detoxifying mechanisms and potential therapeutic options

  2012cites this paper
• Quality Control of HDL: Nutrition and Not Numbers May Determine HDL Functionality

  2011cites this paper
• Impaired Biologic Activities

  2011cites this paper
• Impact of HDL oxidation by the myeloperoxidase system on sterol efflux by the ABCA1 pathway.

  2011cites this paper
• Inflammation, high-density lipoprotein and cardiovascular dysfunction

  2011cites this paper
• Metabolic and functional relevance of HDL subspecies

  2011cites this paper
• HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms

  2011cites this paper
• Tyrosine-lipid peroxide adducts from radical termination: para coupling and intramolecular Diels-Alder cyclization.

  2010cites this paper
• Relative roles of various efflux pathways in net cholesterol efflux from macrophage foam cells in atherosclerotic lesions

  2010cites this paper
• Lipid oxidation by hypochlorous acid: chlorinated lipids in atherosclerosis and myocardial ischemia

  2010cites this paper
• Atherosclerotic lesions in mouse and man: is it the same disease?

  2010cites this paper
• ApoA-1 in Diabetes: Damaged Goods

  2010cites this paper